Cargando…
Bone Morphogenetic Protein 6 Inhibits the Immunomodulatory Property of BMMSCs via Id1 in Sjögren's Syndrome
Mesenchymal stem cells (MSCs) treatment has emerged as a promising approach for treating Sjögren's syndrome (SS). Impaired immunoregulatory activities of bone marrow mesenchymal stem cells (BMMSCs) are found in both SS patients and animal models, and the underlying mechanism is poorly understoo...
Autores principales: | Su, Yingying, Gu, Yi, Wu, Ruiqing, Wang, Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6098892/ https://www.ncbi.nlm.nih.gov/pubmed/30174696 http://dx.doi.org/10.1155/2018/9837035 |
Ejemplares similares
-
Inhibition of bone morphogenetic protein 6 receptors ameliorates Sjögren’s syndrome in mice
por: Yin, Hongen, et al.
Publicado: (2020) -
Evaluation of BMMSCs-EPCs sheets for repairing alveolar bone defects in ovariectomized rats
por: Wen, Yi, et al.
Publicado: (2017) -
MicroRNA-378 Promotes Osteogenesis-Angiogenesis Coupling in BMMSCs for Potential Bone Regeneration
por: Zhang, Bo, et al.
Publicado: (2018) -
Exosomes Derived from BMMSCs Mitigate the Hepatic Fibrosis via Anti-Pyroptosis Pathway in a Cirrhosis Model
por: Zhang, Yichi, et al.
Publicado: (2022) -
Effect of HO-1-modified BMMSCs on immune function in liver transplantation
por: Li, Peng, et al.
Publicado: (2022)